Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,053

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975

Drug-induced prolongation of the QT interval

Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682

Risk Stratification in the Long-QT Syndrome

Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,456

MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia

Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,353

Approaches to Sudden Death from Coronary Heart Disease

Lown, B., & Wolf, M. A. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,258

Atypical antipsychotic drugs and the risk of sudden cardiac death

Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Drug-induced liver injury: Towards early prediction and risk stratification

Raschi, E., & Ponti, F. D. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i1.30 · Cited by 28

A Novel Risk Stratification Score for Sudden Cardiac Death Prediction in Middle-Aged, Nonischemic Dilated Cardiomyopathy Patients: The ESTIMATED Score

Li, X., Fan, X., Li, S., Sun, W., Shivkumar, K., Zhao, S., Lu, M., & Yao, Y. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.11.009 · Cited by 28

Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients

Das, B., Ramasubbu, S. K., Agnihotri, A., Kumar, B., & Rawat, V. S. (2021) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447211058892 · Cited by 30

Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial

Schrijver, E. J. M., de Vries, O. J., Verburg, A., de Graaf, K., Bet, P. M., van de Ven, P. M., Kamper, A. M., Diepeveen, S. H. A., Anten, S., Siegel, A., et al. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-96 · Cited by 28

A dangerous fruit juice

Agosti, S., Casalino, L., Bertero, G., Barsotti, A., Brunelli, C., & Morelloni, S. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2010.08.031 · Cited by 28

Acquired Long QT Syndrome: Frequency, Onset, and Risk Factors in Intensive Care Patients

Kozik, T. M., & Wung, S. (2012) · Critical Care Nurse · doi:10.4037/ccn2012900 · Cited by 26

Prevalence of QT interval prolonging drug–drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study

Khan, Q., Ismail, M., Haider, I., & Khan, F. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0532-5 · Cited by 28

Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium

Vandael, E., Marynissen, T., Reyntens, J., Spriet, I., Vandenberghe, J. U., Willems, R., & Foulon, V. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-9953-6 · Cited by 27

High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia

Moreno‐Gutiérrez, P. A., Gaviria‐Mendoza, A., Montoya-Cañón, M., & Machado‐Alba, J. E. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12969 · Cited by 28

Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes

Ramalho, D., & Freitas, J. P. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.07.010 · Cited by 35

Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms

Capecchi, P. L., Pasini, F. L., El‐Sherif, N., Qu, Y., Boutjdir, M., & Lazzerini, P. E. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.02.017 · Cited by 27

Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program

Sugrue, A. M., Křemen, V., Qiang, B., Sheldon, S. H., DeSimone, C. V., Sapir, Y., Striemer, B. L., Brady, P. A., Asirvatham, S. J., Ackerman, M. J., et al. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6619-0 · Cited by 26

QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes

Kaye, A. D., Volpi-Abadie, J., Bensler, J. M., Kaye, A. M., & Diaz, J. H. (2013) · Journal of Anesthesia · doi:10.1007/s00540-013-1564-1 · Cited by 26

Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure

Rocca, R. L., Ferrari‐Toninelli, G., & Patanè, S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.095 · Cited by 25

Mechanisms of torsades de pointes: an update

Tsuji, Y., Yamazaki, M., Shimojo, M., Yanagisawa, S., Inden, Y., & Murohara, T. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1363848 · Cited by 25

State of the art of mobile health technologies use in clinical arrhythmia care

Sridhar, A. R. M., Cheung, J. W., Lampert, R., Silva, J. N. A., Gopinathannair, R., Sotomonte, J. C., Tarakji, K. G., Fellman, M., Chrispin, J., Varma, N., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00618-4 · Cited by 30

Voriconazole associated torsades de pointes in two adult patients with haematological malignancies

Brown, J. D., Lim, L., & Koning, S. I. (2014) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2014.03.001 · Cited by 25

Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block

Cho, M. S., Nam, G., Kim, Y.-G., Hwang, K.-W., Kim, Y. R., Choi, H., Kim, S., Rhee, K., Kim, N.-J., Kim, J. S., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.11.018 · Cited by 25

Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia

Kim, H. J., Lee, H., Jung, Y. S., Lee, J., Min, J. J., Hong, D. M., Choi, E., Oh, S., & Jeon, Y.-T. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet335 · Cited by 23

The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis

Mega, T. A., Mulugeta, T., Bosho, D. D., Kumela, K., & Negera, G. Z. (2020) · Canadian Respiratory Journal · doi:10.1155/2020/4312519 · Cited by 25

Spatially Discordant Repolarization Alternans in the Absence of Conduction Velocity Restitution

Huang, C., Song, Z., Landaw, J., & Qu, Z. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.02.008 · Cited by 24

The relationship between atypical antipsychotics drugs, QT interval prolongation, and torsades de pointes: implications for clinical use

Díaz, J. C., Frenkel, D., & Aronow, W. S. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1745184 · Cited by 26

Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes

Lazzerini, P. E., Bertolozzi, I., Acampa, M., Cantara, S., Castagna, M. G., Pieragnoli, L., D’Errico, A., Rossi, M., Bisogno, S., El‐Sherif, N., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00684 · Cited by 24

A case of torsades de pointes induced by the third-generation EGFR-TKI, osimertinib combined with moxifloxacin

Bian, S., Tang, X., & Lei, W. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01217-4 · Cited by 24

Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer

Hasegawa, K., Ito, H., Kaseno, K., Miyazaki, S., Shiomi, Y., Tama, N., Ikeda, H., Ishida, K., Uzui, H., Ohno, S., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.017267 · Cited by 23

Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine

Rossi, M., Marzi, F., Natale, M., Porceddu, A., Tuccori, M., Lazzerini, P. E., Pasini, F. L., & Capecchi, P. L. (2021) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00234-x · Cited by 26

Subtle QRS changes are associated with reduced ejection fraction, diastolic dysfunction, and heart failure development and therapy responsiveness: Applications for artificial intelligence to ECG

García‐Escobar, A., Vera, S., y, A. J.-R., Jiménez‐Valero, S., Galeote, G., & Moreno, R. (2022) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12998 · Cited by 23

Assessment of Drug-Induced Torsade de Pointes Risk for Hospitalized High-Risk Patients Receiving QT-Prolonging Agents

Jardin, C. G. M., Putney, D. R., & Michaud, S. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013512614 · Cited by 23

Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis

Lazzerini, P. E., Capecchi, P. L., Bertolozzi, I., Morozzi, G., Lorenzini, S., Simpatico, A., Selvi, E., Bacarelli, M. R., Acampa, M., Lazaro, D. M., et al. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00031 · Cited by 23

Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study

Khan, Q., Ismail, M., & Khan, S. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0181-2 · Cited by 23

Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients

Das, B., Rawat, V. S., Ramasubbu, S. K., & Kumar, B. (2019) · Therapies · doi:10.1016/j.therap.2019.03.008 · Cited by 24

Impact of left ventricular hypertrophy on QT prolongation and associated mortality

Haugaa, K. H., Bos, J. M., Borkenhagen, E. J., Tarrell, R. F., Morlan, B. W., Caraballo, P. J., & Ackerman, M. J. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.06.025 · Cited by 24

Medical decision support systems and therapeutics: The role of autopilots

Woosley, R. L., Whyte, J. J., Mohamadi, A., & Romero, K. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.259 · Cited by 23

Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: The Jackson Heart Study

Akylbekova, E. L., PAYNE, J. P., Newton‐Cheh, C., May, W. L., Fox, E. R., WILSON, J. G., Sarpong, D. F., Taylor, H. A., & Maher, J. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.10.009 · Cited by 22

Measurement and Rate Correction of the QT Interval

Pickham, D. M., & Hasanien, A. A. (2013) · AACN Advanced Critical Care · doi:10.1097/nci.0b013e318274ba3e · Cited by 22

Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings

Ettlin, R. A., Kuroda, J., Plassmann, S., & Prentice, D. E. (2010) · Journal of Toxicologic Pathology · doi:10.1293/tox.23.189 · Cited by 23

Don't fuel the fire: decreasing intravenous haloperidol use in high risk patients via a customized electronic alert

Pell, J. M., Cheung, D., Jones, M. A., & Cumbler, E. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002777 · Cited by 22

Providers’ Response to Clinical Decision Support for QT Prolonging Drugs

Sharma, S., Bos, J. M., Tarrell, R. F., Simon, G., Morlan, B. W., Ackerman, M. J., & Caraballo, P. J. (2017) · Journal of Medical Systems · doi:10.1007/s10916-017-0803-7 · Cited by 22

Incidence and outcomes of long QTc in acute medical admissions

Mahmud, R., Gray, A. T., Nabeebaccus, A., & Whyte, M. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13250 · Cited by 23

Quasi-Experimental Study to Improve Nurses' QT-Interval Monitoring: Results of QTIP Study

Pickham, D. M., Shinn, J. A., Chan, G. K., Funk, M., & Drew, B. J. (2012) · American Journal of Critical Care · doi:10.4037/ajcc2012245 · Cited by 22

Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system

Ali, Z., Ismail, M., Khan, F., & Sajid, H. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1846717 · Cited by 21

Considerations on Safety Concerns About Citalopram Prescribing

Sheeler, R. D., Ackerman, M. J., Richelson, E., Nelson, T. K., Staab, J. P., Tangalos, E. G., Dieser, L. M., & Cunningham, J. L. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.07.009 · Cited by 21

Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations

Furutani, K., Tsumoto, K., Chen, I., Handa, K., Yamakawa, Y., Sack, J. T., & Kurachi, Y. (2019) · The Journal of General Physiology · doi:10.1085/jgp.201812192 · Cited by 21

Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit

Stollings, J. L., Boncyk, C. S., Birdrow, C. I., Chen, W., Chandrasekhar, R., Gupta, D. K., Roden, D. M., Rivera, E. L., Maiga, A. W., Rakhit, S., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.52034 · Cited by 25

Chemotherapy and QT Prolongation: Overview With Clinical Perspective

Kim, P. Y., & Ewer, M. S. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0303-8 · Cited by 20

Post-acute management of the acquired long QT syndrome

Barra, S., Agarwal, S., Begley, D., & Providencia, R. A. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-132398 · Cited by 20

Sudden Cardiac Death

Risgaard, B., Winkel, B. G., Jabbari, R., Lynge, T. H., Wissenberg, M., Glinge, C., Haunsø, S., Behr, E. R., Fink‐Jensen, A., Gislason, G., et al. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.12.023 · Cited by 21

Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis

Sasaki, T., Svensson, E. M., Wang, X., Wang, Y., Hafkin, J., Karlsson, M. O., & Mallikaarjun, S. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01608-21 · Cited by 20

How to manage various arrhythmias and sudden cardiac death in the cardiovascular intensive care

Kobayashi, Y. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0292-x · Cited by 20

Drug-drug interactions between antiemetics used in cancer patients

Umar, R. M. (2018) · Journal of Oncological Sciences · doi:10.1016/j.jons.2018.07.003 · Cited by 20

Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection

Moschini, L., Loffi, M., Regazzoni, V., Tano, G. D., Gherbesi, E., & Danzi, G. B. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01671-4 · Cited by 19

Methadone‐associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program

Titus-Lay, E. N., Jaynes, H. A., Muensterman, E. T., Walroth, T. A., Ott, C. A., Desta, Z., Williams, G., Moe, P. R., Wilbrandt, M., & Tisdale, J. E. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2498 · Cited by 19

Quality of Heart Failure Care in the Intensive Care Unit

Metkus, T. S., Lindsley, J. P., Fair, L., Riley, S. J., Berry, S. A., Sahetya, S. K., Hsu, S., & Gilotra, N. A. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.08.001 · Cited by 22

The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trial

Duprey, M. S., Al‐Qadheeb, N. S., Roberts, R. J., Skrobik, Y. K., Schumaker, G. L., & Devlin, J. W. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4512-3 · Cited by 19

The relationship between serum potassium concentrations and electrocardiographic characteristics in 163,547 individuals from primary care

Krogager, M. L., Kragholm, K. H., Skals, R. K., Mortensen, R. N., Polcwiartek, C., Graff, C., Nielsen, J. B., Kanters, J. K., Holst, A. G., Søgaard, P., et al. (2019) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2019.09.005 · Cited by 20

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic

Romani, S., Gérard, A. O., Fresse, A., Viard, D., Obberghen, E. K. V., Micallef, J., Rocher, F., Drici, M., & the French Pharmacovigilance Network (2020) · Clinical and Translational Science · doi:10.1111/cts.12883 · Cited by 19

Effect of QT Prolongation in Patients Taking Cholinesterase Inhibitors (Donepezil) for Alzheimer’s Disease

Kuwahata, S., Takenaka, T., Motoya, T., Masuda, K., Yonezawa, H., Shinchi, S., Kawashima, Y., Mohri, S., & Ohishi, M. (2021) · Circulation Reports · doi:10.1253/circrep.cr-20-0115 · Cited by 19

Life-threatening cardiac arrhythmias due to drug-induced QT prolongation

Michels, G., Kochanek, M., & Pfister, R. (2015) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-015-0071-6 · Cited by 20

Should We be Worried About QTc Prolongation Using Citalopram? A Review

Hutton, L. M. J., Cave, A., Jean, R. S., & Banh, H. L. (2016) · Journal of Pharmacy Practice · doi:10.1177/0897190015624862 · Cited by 19

American Heart Association

Carey, M. G., Beckie, T. M., & Yates, B. C. (2011) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31821ddd89 · Cited by 19

Donepezil-induced QTc prolongation: A case report

Vogel, S. M., Mican, L. M., & Smith, T. L. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.05.128 · Cited by 18

QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection

Banai, A., Szekely, Y., Lupu, L., Borohovitz, A., Levi, E., Ghantous, E., Taieb, P., Hochstadt, A., Banai, S., Topilsky, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.869089 · Cited by 18

QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with “Known Risk of Torsades de Pointes”

Ryan, K., Benz, P., Zosel, A. E., Farkas, A., & Theobald, J. L. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09764-4 · Cited by 18

The QTc Effect of Low-Dose Methadone for Chronic Pain: A Prospective Pilot Study

Grodofsky, S. R., Edson, E., Huang, S., Speck, R. M., Hatchimonji, J. S., Lacy, K. E., Farrar, J. T., & Ashburn, M. A. (2015) · Pain Medicine · doi:10.1111/pme.12658 · Cited by 18

Pro- and antiarrhythmic effects of ATP-sensitive potassium current activation on reentry during early afterdepolarization-mediated arrhythmias

Chang, M. G., de Lange, E., Calmettes, G., Garfinkel, A., Qu, Z., & Weiss, J. N. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.12.017 · Cited by 18

The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial

and the INCA trial group, Casper, M., Mengel, M., Fuhrmann, C., Herrmann, E. M., Appenrodt, B., Schiedermaier, P., Reichert, M., Bruns, T., Engelmann, C., et al. (2015) · Trials · doi:10.1186/s13063-015-0594-4 · Cited by 18

Sudden Cardiac Death and Disorders of the QT Interval: Anesthetic Implications and Focus on Perioperative Management

Ramakrishna, H., O’Hare, M., Mookadam, F., Gutsche, J. T., Shah, R. S., & Augoustides, J. G. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.07.026 · Cited by 17

Recent developments in the science of proarrhythmic cardiac safety of new drugs

Turner, J. R., Karnad, D. R., Cabell, C. H., & Kothari, S. (2016) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw045 · Cited by 18

Medical toxicologists’ practice patterns regarding drug-induced QT prolongation in overdose patients: A survey in the United States of America, Europe, and Asia Pacific region

Othong, R., Devlin, J. J., & Kazzi, Z. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1013547 · Cited by 18

Risk Management of Hospitalized Psychiatric Patients Taking Multiple QTc-Prolonging Drugs

Vandael, E., Vandenberk, B., Willems, R., Reyntens, J., Vandenberghe, J. U., & Foulon, V. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000758 · Cited by 20

Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Lee, J. Y., Ang, A. S. Y., Ali, N. M., Ang, L. M., & Omar, A. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00370-3 · Cited by 19

Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy

Afşin, A., Asoğlu, R., Kobat, M. A., Asoğlu, E., & Süner, A. (2020) · Cardiology Research · doi:10.14740/cr1185 · Cited by 17

QT interval and drug therapy

Bulletin, D. A. T. (2016) · BMJ · doi:10.1136/bmj.i2732 · Cited by 18

High prevalence of the risk factors for QT interval prolongation and associated drug–drug interactions in coronary care units

Khan, Q., Ismail, M., & Haider, I. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1516106 · Cited by 17

Sources of QTc variability: Implications for effective ECG monitoring in clinical practice

Hnatkova, K., & Malík, M. (2019) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12730 · Cited by 17

Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma

Schwartz, G., Darling, J. O., Mindo, M., & Damicis, L. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00736-8 · Cited by 17

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients

Russo, V., Carbone, A., Mottola, F. F., Mocerino, R., Verde, R., Attena, E., Verde, N., Micco, P. D., Nunziata, L., Santelli, F., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.582348 · Cited by 17

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California

Katrak, S. S., Lowenthal, P., Shen, R. V., True, L., Henry, L., & Barry, P. M. (2021) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2021.100216 · Cited by 17

Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US Veterans

Lazzerini, P. E., Cartocci, A., Qu, Y. S., Saponara, S., Furini, S., Fusi, F., Fabris, F., Gamberucci, A., El‐Sherif, N., Cevenini, G., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010042 · Cited by 17

Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome

Lazzerini, P. E., Pasini, F. L., Boutjdir, M., & Capecchi, P. L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.730161 · Cited by 17

QT prolongation in the STREAM Stage 1 Trial

Hughes, G., Bern, H., Chiang, C.-Y., Goodall, R. L., Nunn, A., Rusen, I. D., & Meredith, S. K. (2022) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0403 · Cited by 17

Fatal Cardiac Arrest in 2 Children

Brenner, S. M., & Boucher, J. (2015) · Pediatric Emergency Care · doi:10.1097/pec.0000000000000317 · Cited by 17

Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case–Control Study

Juba, K. M., Khadem, T. M., Hutchinson, D. J., & Brown, J. E. (2017) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0411 · Cited by 17

Evaluation of knowledge, attitude and practice of healthcare providers towards life-threatening drug-drug interactions in Penang General Hospital, Malaysia

Abdo, M. S., Hammad, M. A., Harun, S. N., Eusoff, T. M., & Ghadzi, S. M. S. (2020) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2020.04.023 · Cited by 17

Corrected QT-interval prolongation and variability in intensive care patients

Hoogstraaten, E., Rijkenberg, S., & van der Voort, P. H. J. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.05.005 · Cited by 18

Remote noninvasive allograft rejection monitoring for heart transplant recipients: study protocol for the novel evaluation with home electrocardiogram and remote transmission (NEW HEART) study

Doering, L. V., Hickey, K. T., Pickham, D. M., Chen, B. C., & Drew, B. J. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-14 · Cited by 17

The incidence, predictors and outcomes of QTc prolongation in critically ill patients

Russell, H., Churilov, L. P., Toh, L., Eastwood, G. M., & Bellomo, R. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.09.014 · Cited by 16

Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study

Li, R., Ma, J.-B., Yang, H. B., Yang, H., Yang, X.-J., Wu, Y., & Ren, F. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01048-23 · Cited by 16

Cardiac Dysrhythmias and Anesthesia

Lorentz, M. N., & Vianna, B. S. B. (2011) · Brazilian Journal of Anesthesiology · doi:10.1016/s0034-7094(11)70090-3 · Cited by 16

Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Spriet, I., Willems, R., & Foulon, V. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0242-9 · Cited by 15

Utility of QT interval corrected by Rautaharju method to predict drug-induced torsade de pointes

Othong, R., Wattanasansomboon, S., Kruutsaha, T., Chesson, D. W., Vallibhakara, S. A.-O., & Kazzi, Z. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1510501 · Cited by 16

Impact of a clinical decision support tool targeting QT-prolonging medications

Chernoby, K., Lucey, M. F., Hartner, C. L., Dehoorne-Smith, M. L., & Edwin, S. B. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa269 · Cited by 16

Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation

Lazzerini, P. E., Accioli, R., Acampa, M., Zhang, W., Verrengia, D., Cartocci, A., Bacarelli, M. R., Xin, X., Salvini, V., Chen, K.-S., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.893681 · Cited by 17

Ciprofloxacin-induced torsade de pointes

Ibrahim, M., & Omar, B. A. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2010.09.039 · Cited by 16

Pain medication and long QT syndrome

Klivinyi, C., & Bornemann‐Cimenti, H. (2018) · The Korean journal of pain · doi:10.3344/kjp.2018.31.1.3 · Cited by 16

QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations

Gotta, V., & Donner, B. C. (2025) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-025-10010-x · Cited by 15

The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients

Fan, W., Liu, H., Shen, Y., & Hong, K. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07425-4 · Cited by 15

QT Prolongation, T orsade de P ointes, Myocardial Ischemia From Coronary Vasospasm, and Headache Medications. Part 1: Review of Serotonergic Cardiac Adverse Events With a Triptan Case

Stillman, M. J., Tepper, S. J., Tepper, D., & Cho, L. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02300.x · Cited by 15

Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center

Lee, R. A., Guyton, A., Kunz, D. F., Cutter, G., & Hoesley, C. J. (2015) · Journal of Hospital Medicine · doi:10.1002/jhm.2448 · Cited by 15

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Sridhar, A. R. M., Chatterjee, N. A., Saour, B., Nguyen, D. D., Starnes, E., Johnston, C., Green, M. L., Roth, G. A., & Poole, J. E. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.06.002 · Cited by 15

Prevention of Torsade de Pointes in Hospital Settings A Scientific Statement From the American Heart Association and the

Menon, V., Roden, D. M., Zareba, W., Drew, B. J., Ackerman, M. J., Funk, M., & Gibler, W. B. (2010)

2010 AHA/ACCF Scientific Statement for Prevention of Torsade de Pointes in Hospital Settings

Chong-bai, X. (2011) · Advances in Cardiovascular Diseases

Incidence of Torsade de Pointes in a teriary hospital population

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Pincé, H., Willems, R., & Foulon, V. (2016) · Acta Cardiologica

[Torsades de pointes].

Kishi, F., Nomura, M., Saito, K., Ito, S., & Nakaya, Y. (1996) · PubMed

Torsade de pointes.

Santinelli, V., Chiariello, M., & Condorelli, M. (1982) · Circulation · doi:10.1161/01.cir.66.1.250 · Cited by 6